ResMed Inc. (LON:0KW4)
249.70
+0.99 (0.40%)
At close: Nov 7, 2025
ResMed Employees
ResMed had 10,600 employees as of June 30, 2025. The number of employees increased by 620 or 6.21% compared to the previous year.
Employees
10,600
Change (1Y)
620
Growth (1Y)
6.21%
Revenue / Employee
368.98K GBP
Profits / Employee
100.92K GBP
Market Cap
27.88B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 10,600 | 620 | 6.21% |
| Jun 30, 2024 | 9,980 | -160 | -1.58% |
| Jun 30, 2023 | 10,140 | 1,980 | 24.26% |
| Jun 30, 2022 | 8,160 | 190 | 2.38% |
| Jun 30, 2021 | 7,970 | 200 | 2.57% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| Spire Healthcare Group | 15,703 |
| ConvaTec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| Genus | 3,190 |
ResMed News
- 6 days ago - RMD: Baird Lowers Price Target for ResMed to $300 While Maintaining Outperform Rating | RMD ... - GuruFocus
- 8 days ago - RMD: RBC Capital Raises Price Target, Maintains Outperform Rating | RMD Stock News - GuruFocus
- 8 days ago - Keybanc Analyst Raises ResMed (RMD) Price Target to $299 | RMD Stock News - GuruFocus
- 9 days ago - Mizuho Maintains 'Outperform' for RMD but Lowers Price Target | RMD Stock News - GuruFocus
- 9 days ago - These Analysts Revise Their Forecasts On ResMed Following Q1 Results - Benzinga
- 9 days ago - These Analysts Revise Their Forecasts On ResMed Following Q1 Results - Benzinga
- 9 days ago - ResMed declares $0.60 dividend - Seeking Alpha
- 9 days ago - Resmed Stock Up on Q1 Earnings & Revenue Beat, Margins Expand - Nasdaq